tiprankstipranks
Trending News
More News >
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market

Compare Sagimet Biosciences, Inc. Class A (SGMT) vs. Competitors

Compare
1,677 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Sagimet Biosciences, Inc. Class A
$5.67
$175.78M
-3.17
39.66%
7 Buy
1 Hold
0 Sell
Strong Buy
Codexis
$1.24
$112.00M
-1.65
-72.44%
3 Buy
2 Hold
0 Sell
Moderate Buy
Cabaletta Bio
$2.75
$247.40M
-1.02
9.83%
6 Buy
1 Hold
0 Sell
Strong Buy
Black Diamond Therapeutics
$2.49
$141.87M
6.86
-1.19%
4 Buy
1 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$4.24
$331.26M
-2.39
41.81%
2 Buy
0 Hold
0 Sell
Moderate Buy
Entrada Therapeutics Inc
$11.44
$437.23M
-4.57
-14.44%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SGMT
Sagimet Biosciences, Inc. Class A
5.67
1.01
21.67%
CDXS
Codexis
1.24
-3.03
-70.96%
CABA
Cabaletta Bio
2.57
0.21
8.90%
BDTX
Black Diamond Therapeutics
2.49
0.04
1.63%
AVIR
Atea Pharmaceuticals
4.24
1.32
45.21%
TRDA
Entrada Therapeutics Inc
11.44
-1.89
-14.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts